BioDelivery Sciences (BDSI) Tops Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Cantor Fitzgerald Loweres PT Despite BioDelivery Sciences' (BDSI) Earnings Beat
May 12, 2015 7:45 AM EDTCantor Fitzgerald maintains a Buy rating on BioDelivery Sciences International (NASDAQ: BDSI), but lowered the price target to $12.00 (from $17.00). Despite the 1Q15 earnings beat by BDSI, Cantor Fitzgerald lowered the price target due to BUNAVAIL's revenue miss. BDSI reported revenue of $13.1M and a... More
